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Purpose 
To understand the current state of the evidence regarding 
translation of genetics and genomics into nursing care of 
children with (ASD) 
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 Autism first introduced as a developmental disability or 
“pervasive developmental disorders” (PDD) (Diagnostic and 
Statistical Manual of Mental Disorders [DSM-III] American Psychiatric Association [APA], 
1980) 
 
 
 PDD-Not Otherwise Specified (PDD-NOS) added in the 
revised DSM III-R (APA, 1987)  
 
 Asperger’s disorder added as a PDD in the DSM-IV and 
the DSM-IV TR (APA, 1994; 2000) and the International 
Classification of Diseases, tenth edition International Statistical 
Classification of Diseases and Related Health Problems  (ICD-10), (World Health 
Organization [WHO], 1992)  
Defining ASD 
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Rising Prevalence of ASD 
 1940’s until the 1980’s 1/2000 (0.05%)  
 Now 
– 6-7/ 1,000 children (0.6%–0.7%).  
– >1%  
– 2.6% among children in areas of Asia, Europe, and 
North America.  
– 4-5 boys are affected for every girl. 
 
(Centers for Disease Control and Prevention (CDC), 2012; Fombonne, 2009; Kim et 
al., 2011) 
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ASD Phenotype  
 
 Numerous phenotypic dimensions suggests causal 
heterogeneity  
 
 Core domains associated with ASDs (social, 
communication, restricted, repetitive behaviors) 
distributed in a more continuous way in the population 
 
 (Walsh, Elsabbagh, Bolton, & Singh, 2011; Constantino, 2011) 
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Heritability 
 
 Identical twins shared 60% to 90% of autistic traits 
compared to fraternal twins who only shared 0% to 
10%(Rosenberg et al., 2009) 
 
 Sibling recurrence as high as 19% (Ozonoff et al., 2011) 
 
 Co-occurrence of ASD and single gene disorders (e.g. 
tuberous sclerosis) (Freitag, Staal, Klauck, Duketis,  & Waltes, 2010) 
 
 No single risk factor explains the changes identified in 
ASD prevalence over time (Rice, 2011) 
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 Environmental factors (influences other than genetic 
mutations) (Hallmeyer et al., 2011) 
 Gestational exposure to high levels of environmental 
pollutants, for eg.  pesticides (Shelton, Hertz-Picciotto, & Pessah, 
2012) 
 Complications during pregnancy, for eg. viral 
infections, maternal stress (Altadottir et al.,2010; Kinney, Munir, 
Crowley, & Miller, 2008) 
 Artificial insemination and ovulation-inducing drugs in 
mothers ≥35 years old (Lyall, Pauls, Spiegelman, Santangelo, & 
Ascherio, 2012) 
 
 
 
 
Environment 
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Environmental Epigenetics 
 Study of changes in gene expression that occur without 
changes in DNA sequence 
 
 Histone methylation is different in persons with ASD 
compared to controls on genes regulating neuronal 
connectivity, social behaviors, and cognition (Shulha et al., 
2012) 
 
 Early Autism Risk Longitudinal Investigation (EARLI) 
(www.earlistudy.org)]  
– Hypothesis: epigenetic changes from methylation 
related to environmental exposure during pregnancy 
might increase the risk of ASD  
 
 
 
The Promise of Genetics 
 An understanding of molecular and cellular mechanisms 
promises to: 
 Improve the opportunities to intervene in a rational way and  
 Lead to the path to treatment or cure. 
 
 Why so hard to find the genetic answer? 
 Individuals are ~99% identical, genetically 
 Highly heterogeneous disorder 
 Until very recently, limited ability to search through the 
genome  
 Often not due to single gene ….not a 1 to 1 relationship 
between genetic risk and outcome 
 Variations are the basis for genetic risk 
 
 ASD research is interested in the ~1% difference 
• . 
 Very little is known about diversity in systems-level brain architecture 
 
 Not sure what is normal and what is atypical 
 
 Genetic influences emerge from rare variants                                           or 
may have small, cummulative effects 
 
 Research is in infancy 
• Needs ways to connect genetic variation                                                                         
to specific behaviors 
• Then apply to ASD and subgroups 
 
 Following significant leads 
• “Father’s age linked to risk for autism                                                                                 
and schizophrenia”, 2012 
• “Grandfather’s age linked to risk of autism”, 2013 
Research of ASD: 
 Gene and Variation Discovery 
VARIATIONS 
• Single nucleotide 
polymorphisms   
• Structural  gains and losses of 
genetic materials at 
submicroscopic resolution 
(CNV) 
• Common and rare variations 
mutations contribute to ASD 
risk 
– Nature of contributions is 
open to debate 
 
SINGLE GENES MUTATIONS 
• Rate mutations in “syndromic” 
and “idiopathic” ASD point to 
complex mechanisms 
• Some syndrome and medical 
conditions are attributable to 
single genes 
• Unlikely there is only one 
path to the disorder 
 
 
Single genes: Associated syndromes and  
medical conditions 
 
Individuals with the following conditions account for~ 5-10 
% of cases of ASD 
 
 Sex chromosome trisomies,  XYY and Klinefelter syndrome 
(XXY)  
 Fragile X, Rett  
 Tuberous Sclerosis 
 Smith-Magenis 
 Angelman, Pader-Willi  
 Velocardiofacial (deletion 22q11.q) 
 Large de novo CNV (~500 kbp) account for about 6-10% of ASD 
• Carry  large, clearly identifiable, risks 
• Inheritance assessment suggests that 1/3 rd are de  novo 
  New hotspots emerging eg. 15q25 highlighting 
• specific genes IMMP2L, ATXBP1, CTNNA3 (1-2% of  patients) 
 
 
 
 
 
Structural gains and losses of genetic materials 
called copy number variants (CNV) 
Identifying 
Copy Number  
Variants 
 16p11.2 deletions and duplications 
• 1% of cases of “idiopathic” ASD 
 7q11.23 duplications strongly associated with ASD 
• This  is the Williams syndrome region 
• Ch 7- speech and language disorders 
 4 regions have recurrent de novo and rare transmitted 
CNVs (found only in cases of ASD)  
• 1q21.1 
• 15q13.3    [**anxiety and epilepsy] 
• 16p13.2 
• 16q23.3 
 
 
 
Copy number variants 
 Rare and common mutations may contribute to ASD risk 
• Cerebellum development  
 ( EN2 -Engrailed 2 gene, Chr 7)  
• Brain cell migration, differentiation, and synapse 
formation 
  (gamma aminobutyric acid receptor genes, Chr 4, 5, 15) 
• Stress response social skills  
 (OXTR -oxytocin receptor genes, Chr 3) 
• Neuronal migration in developing brain 
  (RELN -Reelin gene, Chr 7) 
• Serotonin transport  
 ( SLC6A4- a serotonin transporter gene, Chr 17) (Sakuri, Cai, Grice, & Buxbaum, 
2011) 
Contributions of Common Variants 
Gene Function 
Outcome 
Brain 
Segment 
Gene   Chr 
Developmental 
Disabilities 
 
Intellectual 
Disabilities 
Not Known Several Copy 
number 
variants 
(deletions and 
duplications) 
16 
16p11.2 
Obsessions 
Compulsions 
Depression 
Synapses SLC64A 17q11.2  
  
Cognitive deficits 
Language Disorder 
Speech disorder 
 
 
Synapses Duplication 
SHANK3 
22q11.2 
Chromosomal microarray analysis 
Comparative genomic hybridization (CGH) 
 
 
 Method for the analysis of copy number variants (gains/losses) 
in the entire genome 
 Considered medically necessary for diagnosing a genetic 
abnormality in children with apparent non-syndromic ASD 
when: 
– Biochemical test for metabolic disease is non-diagnostic, AND 
– FMR1 gene analysis (for Fragile X syndrome), when clinically appropriate, is 
negative, AND 
 The child has one or more of the following (Miller, 2010) 
– Major malformations (dysmorphology) 
– A single major malformation or multiple minor malformations,  
– A single major malformation and multiple minor malformations,  
– The results for the genetic testing have the potential to impact the clinical 
management of the patient,  
– Testing is requested after the parent(s) have face-face genetic counseling. 
 
 
Perceptions of Causes 
• The perceived causes reported most commonly 
by parents of autistic children include  
– Genetic influences                                             (73%) 
•       Only 10% had seen a genetic professional related to an ASD 
– Pregnancy and/or delivery problems                (23%) 
– Childhood illness                                               (20%) 
– Vaccines to child or pregnant mother                (27%) 
– Diet                                                                    (9%) 
– Environmental exposure                                   (11%) 
– Age at birth                                       (mothers-8%, fathers 9%) 
 
(Mercer etal, 2006; Selkirk, 2009) 
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Nursing Implications for Research  
 
 Nurses counsel and refer patients for participation in 
clinical trials 
 The International Society for Autism Research (INSAR) 
interdisciplinary collaboration http://www.autism-
insar.org/ 
 Collaborative consortiums  
 The Autism Genetic Resource Exchange 
http://agre.autismspeaks.org; 
  The Simons Foundation Autism Research Initiative 
http://sfari.org/  
 The Autism Genome Project www.autismgenome.org  
 The National Database for Autism 
Researchhttp://ndar.nih.gov  
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Research Communities 
 Simmons Simplex Community Research ‘Simplex’ 
families (only one child with ASD) helps identify whether 
genetic changes are: 
 inherited from the parent (already present in the 
family) (Fishbach & Lord, 2010) 
 A result of a de novo mutation in the child resulting in 
the potential to connect environmental and genetic 
links to ASD (Sebat et al., 2007) 
 Autism Genetic Resource Exchange  
 Research families participate in research looking for 
ASD candidate genes  (http://agre.autismspeaks.org) 
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Implications for Patient Participation in 
Research 
 Many research methodologies and implications for 
participation (for eg. some research is only aggregate 
findings that may offer no individual clinically useful 
individual information for symptoms and prognosis or  
therapeutic interventions, in the short term) (Miller, Hyeems, & 
Bytautas, 2010) 
 
 Complex to align genes with the behavioral symptoms of 
ASD, which also limits the development of a clinically 
valid genetic test (McMahon et al., 2006) 
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Nursing Implications- Education 
 
 The National Genetics Education and Development 
Center  (http://www.tellingstories.nhs.uk/)  
 
 Know risk factors and how to identify possible signs of 
ASD 
 
 When to refer for additional assessment and intervention 
 
 Family history:  
 Broader autism phenotype in apparently unaffected 
family members, across generations.  
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Nursing Implications-Practice 
 Assess for possible ASD in all child encounters (Centers for 
Disease Control and Prevention, 2012) 
 How a child communicates, interacts, behaves, learns, and 
plays and is guided by diagnostic criteria. 
 Early recognition of autism and for screening all children 
algorithms in the USA  (Johnson & Myers, 2007) and in the United 
Kingdom (National Collaborating Center for Women’s and Children’s Health, 
2010)  
 Without a definitive cause for ASD, parents are left to 
come to their own interpretations for the cause and beliefs 
affect future decisions parents made about health care 
(Hebert & Koulouglioti, 2010) 
 Parents experience stress during diagnosis and need a 
plan for life-long behavioral interventions for the child 
(Giarelli, Souders, Pinto-Martin, Block & Levy, 2005) 
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Clinical Relevance 
 Without a definitive diagnostic test for ASD, diagnosis 
may be delayed.  
 Centers for Disease Control and Prevention 
(www.cdc.gov/autism, www.cdc.gov/actearly). 
 Public education system.  The Individuals with 
Disabilities Education Act (IDEA; http://idea.ed.gov/) 
enables early intervention or special education 
assessment to begin at any time there is a 
developmental concern.  
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Summary 
• Many genes on different chromosomes 
may be involved in ASD 
• Chromosomal disorders and syndromes 
are risk factors for ASD 
• Nurses will continue to play an important 
in research, education, and practice for 
children with ASD and their families’ health 
25 
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Clinical Resources 
 
 Autism Society of America (http://www.autism-society.org 
) 
 Autism Speaks (http://www.autismspeaks.org) 
 National Autistic Society (http://www.autism.org.uk)  
 National Institutes of Health 
http://www.health.nih.gov/topic/Autism  
 National Health Service 
http://www.nhs.uk/conditions/Autistic-spectrum-disorder 
 Vaccine information 
http://www.cdc.gov/vaccines/hcp.htm  
